reason report
price chang estim chang analysi
reiter invest rate increas former
price target per share follow
compani better fiscal consensu expect
subsequ increas revenu earn guidanc
accordingli estim deliv consist trend
favor oper result rel street expect core
tenant recent upgrad link result return mid high
single-digit organ revenu growth coupl double-digit non-
earn growth acceler invest
csi busi begin yield leverag paraguard
comp becom challeng remain encourag
result relat market initi also look continu
acceler single-us sihi sale within pace growth
margin expans throughout accordingli reiter
rate price target share
increas price increas former
price target per share revis
price target assum like multipl approxim
ebitda non-gaap earn
chang estim increas former
revenu non-gaap earn estim reflect
compani fiscal out-perform enhanc
guidanc specif increas former revenu
non-gaap earn estim million
million per share respect revis
estim conserv fall mid-point revis corpor
guidanc addit moder increas former
revenu estim million million
maintain per share non-gaap earn estim
valuat summari share current trade ev/
revenu ebitda non-
earn impli modest discount rel compar
peer see figur trade like multipl
cooper compani inc headquart
pleasanton california global medic product
compani serv specialti healthcar market
two busi unit coopervis
develop market broad rang contact
lens coopersurg csi develop
manufactur market medic devic
diagnost product surgic instrument
import disclosur analyst certif page report access current disclosur stephen
inc cover compani client may refer
guidanc increas increas revenu non-gaap earn guidanc conjunct
compani fiscal out-perform specif compani rais coopervis revenu guidanc
rang million million revis rang million million also increas
coopersurg csi revenu rang million million revis rang million
million result compani forecast revenu rang million impli
pro forma annual revenu growth furthermor compani expect effect tax rate
versu previou expect modest fx headwind versu prior expect
lower interest expens due factor compani fiscal oper result rais
non-gaap earn guidanc rang per share revis rang per share
fiscal oper summari coo fiscal revenu see figur increas year-over-year
million pre-cal consensu coo adjust gross margin declin pre-cal consensu
adjust gross margin declin result fx headwind csi gross margin
increas due favor mix includ paragard well select fertil product
compani quarterli adjust oper margin declin pre-cal consensu result
plan invest sell market infrastructur csi addit report
adjust effect tax rate pre-cal consensu result report non-gaap earn
per share pre-cal consensu per share compani lower forecast effect tax rate contribut
better consensu earn expect
coopervis fiscal oper period sale increas report pro forma basi
pre-cal consensu million region emea increas report pro forma basi
million america sale increas report pro forma basi million lastli asia
pacif revenu increas report pro forma basi million product standpoint
toric quarterli revenu increas report pro forma basi million non single-us
sphere revenu declin report increas pro forma basi million single-
use sphere revenu increas pro forma basi million multifoc revenu
increas report pro forma basi million
exce market growth global soft contact len market grew million impress
exceed market growth grow increas compani market share result
tie number market share slot ciba vision rate nv specif market growth
driven single-us daili dispos len sale increas million total
soft contact len market importantli compani estim daili wearer account low share
total wearer result present signific trade-up opportun market share within daili
coopersurg csi quarterli revenu increas report pro forma basi million pre-
call consensu million csi offic surgic product busi increas report pro forma
million due strength paragard grew repres million
iud market lastli fertil sale increas report pro forma million
balanc sheet review fiscal oper period gener million oper cash flow
incur million capit expenditur yield free cash flow million compani exit
fiscal oper period million cash cash equival million debt net debt
posit million equival net debt per share
outpac market growth take share
good sold cog
gm in-lin expect
 amort intang
continu invest key account paraguard dtc
on-going invest misight
slightli lower net ineterest expens due lower rate
lower drove upsid
consolid gaap statement incom
million except per share data
fiscal period
fiscal period
fiscal period
good sold cog
 amort intang
compani file stephen inc estim
analyst primarili respons prepar content report certifi view express report
accur reflect analyst person view subject compani secur ii part analyst compens
directli indirectli relat specif recommend view express analyst report
